Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2025 10:00 ET | Source: National Association of Realtors®

Home Prices Increased in 77% of Metro Areas in Third Quarter of 2025

Washington, D.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Home prices rose in 77% of metro markets (176 out of 230) during the third quarter of 2025, according to the National Association of REALTORS®’...
November 06, 2025 00:19 ET | Source: Benitec Biopharma Inc.

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering

HAYWARD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
November 05, 2025 16:43 ET | Source: Benitec Biopharma Inc.

Benitec Biopharma Inc. Announces Proposed Public Offering

HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
November 03, 2025 07:10 ET | Source: Benitec Biopharma Inc.

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301

Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has...
November 03, 2025 07:00 ET | Source: Benitec Biopharma Inc.

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
November 02, 2025 19:00 ET | Source: Benitec Biopharma Inc.

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
October 30, 2025 14:05 ET | Source: Advanced Technology Recycling (ATR)

ATR Offers Responsible Recycling Alternative Following BAN’s “Brokers of Shame” Findings

In its new Brokers of Shame investigation, the Basel Action Network (BAN) names ten R2 ITAD companies. Is your provider one of them?
October 29, 2025 13:57 ET | Source: QCI

Win-River Resort & Casino Selects Quick Custom Intelligence Enterprise Platform

SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) and Win-River Resort & Casino are excited to announce a strategic partnership that will elevate the gaming and...
October 29, 2025 10:30 ET | Source: Clearfield, Inc.

Clearfield Elects Rebecca Seidel and Kathleen Skarvan to the Board of Directors

MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Clearfield, Inc. (NASDAQ: CLFD), a leader in community broadband fiber connectivity, today announced the election of Rebecca Seidel and Kathleen...
October 28, 2025 17:16 ET | Source: Bayside Builders Group

Bayside Builders Group Celebrates 115th 5-Star Google Review, Cementing Role as Top-Rated Bathroom Remodeler in Alameda County

Alameda, CA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bayside Builders Group, a fully licensed, bonded, and insured home remodeling contractor, is today celebrating their 115th 5-star Google review. This...